Diabetic nephropathy

Mark E. Molitch, Ralph A. DeFronzo, Marion J. Franz, William F. Keane, Carl Erik Mogensen, Hans Henrik Parving, Michael W. Steffes

Resultado de la investigación: Review articlerevisión exhaustiva

209 Citas (Scopus)


Annual screening for microalbuminuria will allow the identification of patients with nephropathy at a point very early in its course. Improving glycemic control, aggressive antihypertensive treatment, and the use of ACE inhibitors or ARBs will slow the rate of progression of nephropathy. In addition, protein restriction and other treatment modalities such as phosphate lowering may have benefits in selected patients.

Idioma originalEnglish (US)
Páginas (desde-hasta)S85-S89
PublicaciónDiabetes care
EstadoPublished - ene 2002

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialized Nursing


Profundice en los temas de investigación de 'Diabetic nephropathy'. En conjunto forman una huella única.

Citar esto